Apoptosis in chronic myelogenous leukemia: Studies of stage-specific differences

Leukemia and Lymphoma

Volumn 25, Issue 1-2, 1997, Pages 121-133

  Gisslinger, Heinz ^a   Kurzrock, Razelle ^a   Wetzler, Meir ^a   Tucker, Susan ^a   Kantarjian, Hagop ^a   Robertson, Budd ^a   Talpaz, Moshe ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; BCR ABL; Chronic myelogenous leukemia (CML); Growth factors; Neutrophils

Indexed keywords

CYTOKINE; DIPHENYLAMINE; DNA FRAGMENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1BETA;

ADULT; AGED; APOPTOSIS; ARTICLE; BLAST CELL; BONE MARROW CELL; CANCER GROWTH; CANCER STAGING; CELL DEATH; CELL METABOLISM; CELL STRUCTURE; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0030945972     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709042502     Document Type: Article

References (25)

1. Clarkson, B. and Strife, A. (1991). Discordant maturation in chronic myelogenous leukemia, in Deisseroth, A. B., Arlinghaus, R. B (eds): Chronic myelogenous leukemia. Molecular approaches to research and therapy. (New York, NY, Marcel Dekker), 1991, p. 3.
2. Stryckmanns, P. A., Debusscher, L. and Collard, E. (1977). Cell kinetics in chronic granulocytic leukaemia (CGL). Clin. Haematol., 6, 21.
3. Clarkson, B. and Strife, A. (1993). Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia, 7, 1683.
4. McGahon, A., Bissonette, R., Schmitt, M., Cotter, K. M., Green, D. R. and Cotter, T. G. (1994). BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death Blood, 83, 1179.
5. Bedi, A., Zehnbauer, B. A., Barber, J. P., Sharkis, S. J. and Jones, R. J. (1994). Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 83, 2038.
6. Wetzler, M., Talpaz, M., VanEtten, R. A., Hirsch-Ginsberg, C., Beran, M. and Kurzrock, R. (1993). Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Invest., 92, 1925.
7. Metcalf, D. (1985). The granulocyte-macrophage colony-stimulating factors. Science, 229, 16.
8. Klein, H., Becher, R., Lφbbert, M., Oster, W., Schleiermacher, E., Brach, M. A., Souza, L., Lindemann, A., Mertelsmann, R. H. and Herrmann, F. (1990). Synthesis of granulocyte colony-stimulating factor and its requirement for terminal divisions in chronic myelogenous leukemia. J. Exp. Med., 171, 1785.
9. Silver, R. T., Gale, R. P. (1986). Chronic myeloid leukemia Am. J. Med., 80, 1137.
10. Wetzler, M., Kurzrock, R., Estrov, Z., Kantarjian, H., Gisslinger, H., Underbrink, M. P. and Talpaz, M. (1994). Altered levels of interleukin-1β and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates. Blood, 84, 3142.
11. Brach, M. A., deVos, S., Gruss, H. J. and Herrmann, F. (1992). Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood, 80, 2920.
12. Colotta, F., Re, F., Polentarutti, N., Sozzani, S. and Mantovani, A. (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood, 80, 2012.
13. Burton, K. (1956). A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochemistry, 62, 20.
14. Kerr, J. F. R., Wyllie, A. H. and Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer, 26, 239.
15. Ahmed, S. A., Gogal, R. M. and Walsh, J. E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes, an alternative to H3 - thymidine incorporation assay J Immunol. Method, (in press).
16. Ahuja, H., Bar-Eli, M., Arlin, Z., Advani, S., Allen, S. L., Goldman, J., Snyder, D., Foti, A. and Cline, M (1991). The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia J. Clin. Invest., 87, 2042.
17. Daley, G. Q. and Baltimore, D (1988). Transformation of an inlerleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc. Natl. Acad. Sci. USA, 85, 9312
18. Imamura, J., Miyoshi, I. and Koeffler, H. P. (1994). p53 in hematologic malignancies. Blood, 84, 2412.
19. Sirard, C., Laneuville, P. and Dick, J. E. (1994). Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood, 83, 1575.
20. Rodriguez-Cimadevilla, J. C., Beauchemin, V., Villeneuve, L., Letendre, F., Shaw, A. and Hoang, T. (1990). Coordinate secretion of interleukin-1ε and granuloyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducer Blood, 76, 1481.
21. Muroshi, I., Tohuda, S., Suzuki, T., Nagata, K., Yamashita, Y. and Nara, N. (1990). Mechanism of action of interleukin-1 on the progenitors of blast cells in acute myeloblastic leukemia. Exp. Hematol., 18, 133.
22. Armaout, M. A., Wang, E. A., Clark, S. C. and Sieff, C A. (1986). Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J. Clin. Invest., 78, 597.
23. Gordon, M. Y., Dowding, C. R., Riley, G. P., Goldman, J. M. and Greaves, M. F (1987). Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myelogenous leukaemia. Nature, 328, 342.
24. Verfaillie, C. M., McCarthy, J. B. and McGlave, P B. (1992). Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin. Invest., 90, 1232.
25. Wintrobe, M. M. (1981). Clinical Hematotogy. (Lea & Febiger, Philadelphia), p 192.